Possible online services disruption due to Internet related outage
Drugs and Therapeutics (D & T) Committee Drugs Under Review for: June 17, 2009
Drug Name | Review Type | Class | Manufacturer |
---|---|---|---|
Texacort | New Drug Initial Review | Topical Corticosteroid | JSJ |
CNL8 Nail Kit | New Drug Initial Review | Topical Antifungal | JSJ |
Flector Patch | New Drug Initial Review | Topical NSAID | King |
Kapidex | New Drug Initial Review | Proton Pump Inhibitor | Takeda |
Cinryze | New Drug Initial Review | Hereditary Angioedema | ViroPharm |
Banzel | New Drug Initial Review | Anticonvulsant | Eisai |
Vimpat | New Drug Initial Review | Anticonvulsant | UCB |
Durezol | New Drug Initial Review | Ophthalmic- Anti-Inflammatory | Sirion |
Aplenzin | New Drug Initial Review | Antidepressants - Other | Sanofi |
Simponi | New Drug Initial Review | Biologic Modifier | Centocor |
Zanaflex Caps | New Drug Initial Review | Skeletal Muscle Relaxant | Acorda |
Rapaflo | New Drug Initial Review | BPH Agent | Watson |
Gelnique Gel | New Drug Initial Review | Urinary Anti-Incontinence Agent | Watson |
Equetro | New Drug Appeal | Bipolar I Disorder | Validus |
Zemplar | New Drug Appeal | Hyperparathyroidism due to CKD | Abbott |
Trilipix | New Drug Appeal | Lipotropics - Other | Abbott |
Simcor | New Drug Appeal | Lipotropics- Statins & Combinations | Abbott |
Vigamox | PDL Appeal | Ophthalmic - Antibiotics | Alcon |